Exploring the utility of circulating tumor DNA in neoadjuvant setting
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Breast Cancer
- Registration Number
- CTRI/2016/09/007308
- Lead Sponsor
- DEPARTMENT OF BIOTECHNOLOGY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
•Patients just diagnosed with breast cancer and planned for NACT.
•Patients willing to provide written informed consent to participate in the study.
•Patients whose tumors have any receptor phenotype.
•Patients willing to receive the usual standard treatment in NACT setting
Exclusion Criteria
Patients with metastatic disease will not be included.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method